Expression of p63, COX-2, EGFR and ß-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers

International Journal of Oncology

Volumn 27, Issue 6, 2005, Pages 1661-1667

  Boldrup, Linda ^a   Coates, Philip J ^b   Hedberg, Ylva ^a   Sjöström, Björn ^c   Dahlqvist, Åke ^c   Nylander, Karin ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

catenin; COX 2; EGFR; P63; Squamous cell carcinoma of the head and neck

Indexed keywords

BETA CATENIN; CYCLOOXYGENASE 2; DNA BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MEMBRANE PROTEIN; MESSENGER RNA; PHOSPHOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PTGS2 PROTEIN, HUMAN; TP73L PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; GENETICS; HEAD AND NECK TUMOR; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUTH MUCOSA; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOUTH MUCOSA; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKING; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 33644816080     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Macfarlane GJ, Boyle P, Evstifeeva TV, Robertson C and Scully C: Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem. Cancer Causes Control 5: 259-265,1994.
2. Kim MM and Califano JA: Molecular pathology of head-andneck cancer. Int J Cancer 112: 545-553, 2004.
3. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et ah. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 161: 1051-1060, 2002.
4. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR and Braakhuis BJ: Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res 10: 3607-3613, 2004.
5. Yang A, Kaghad M, Wang Y, et ah p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, deathinducing, and dominant-negative activities. Mol Cell 2: 305-316, 1998.
6. Osada M, Ohba M, Kawahara C, et ah Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 4: 839-843,1998.
7. Hibi K, Trink B, Patturajan M, et ah AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 97:5462-5467,2000.
8. Patturajan M, Nomoto S, Sommer M, et ah. DeltaNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell 1: 369-379, 2002.
9. Barker N and Clevers H: Catenins, Wnt signaling and cancer. Bioessays 22: 961-965,2000.
10. He TC, Sparks AB, Rago C, et ah. Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512,1998.
11. Kikuchi A: Regulation of beta-catenin signaling in the Wnt pathway. Biochem Biophys Res Commun 268: 243-248, 2000.
12. Janssens V and Goris J: Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353: 417-439, 2001.
13. Chan G, Boyle JO, Yang EK, et ah. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59: 991-994,1999.
14. Herschman HR, Talley JJ and DuBois R: Cyclooxygenase 2 (COX-2) as a target for therapy and noninvasive imaging. Mol Imaging Biol 5: 286-303, 2003.
15. Terakado N, Shintani S, Yano J, et ah. Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma. Oral Oncol 40: 383-389, 2004.
16. Moraitis D, Du B, De Lorenzo MS, et ah. Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands. Cancer Res 65: 664-670, 2005.
17. Chang YC, Tsai CH, Yang SH, Liu CM and Chou MY: Induction of cyclooxygenase-2 mRNA and protein expression in human gingival fibroblasts stimulated with nicotine. J Periodontal Res 38:496-501,2003.
18. Matheny KE, Barbieri CE, Sniezek JC, Arteaga CL and Pietenpol JA: Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells. Laryngoscope 113: 936-939, 2003.
19. Shintani S, Kiyota A, Mihara M, et ah. Enhancement of radiosensitivity in head and neck cancer cells by ZD1839 ('IRESSA'), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Am J Clin Oncol 26: E150-E156, 2003.
20. Antonyak MA, Moscatello DK and Wong AJ: Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor. J Biol Chem 273: 2817-2822,1998.
21. Moscatello DK, Holgado-Madruga M, Emlet DR, Montgomery RB and Wong AJ: Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor. J Biol Chem 273: 200-206,1998.
22. Prigent SA, Nagane M, Lin H, et ah. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway. J Biol Chem 271: 25639-25645,1996.
23. Takeyama K, Jung B, Shim JJ, et ah. Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol 280: L165-L172,2001.
24. Thurfjell N, Coates PJ, Uusitalo T, et ah. Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck. Int J Oncol 25: 27-35, 2004.
25. Nylander K, Vojtesek B, Nenutil R, et al: Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 198:417-427,2002.
26. Westfall MD, Mays DJ, Sniezek JC and Pietenpol JA: The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol Cell Biol 23: 2264-2276, 2003.
27. Itoh S, Matsui K, Furuta I and Takano Y: Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor. Oral Oncol 39: 829-835, 2003.
28. Araki Y, Okamura S, Hussain SP, et ah Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res 63: 728-734, 2003.
29. Barbieri CE, Perez CA, Johnson KN, Ely KA, Billheimer D and Pietenpol JA: IGFBP-3 is a direct target of transcriptional regulation by DeltaNp63alpha in squamous epithelium. Cancer Res 65: 2314-2320, 2005.
30. Ihrie RA, Marques MR, Nguyen BT, et ah Perp is a p63-regulated gene essential for epithelial integrity. Cell 120: 843-856, 2005.